Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets-Reference-Cited by-同舟云学术

Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets

Published:2014-11 Issue:5 Volume:147 Page:1073-1083.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Fisher Ffolliott M.,Chui Patricia C.,Nasser Imad A.,Popov Yury,Cunniff Jeremy C.,Lundasen Thomas,Kharitonenkov Alexei,Schuppan Detlef,Flier Jeffrey S.,Maratos-Flier Eleftheria

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. Natural history of NAFLD: remarkably benign in the absence of cirrhosis;Day;Gastroenterology,2005

2. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey;Tominaga;Dig Dis Sci,1995

3. Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic;Schattenberg;Curr Opin Lipidol,2011

4. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004

5. Hepatic histology in obese patients undergoing bariatric surgery;Machado;J Hepatol,2006

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets;Biochemical Pharmacology;2024-09

2. FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate;Frontiers in Pharmacology;2024-07-08

3. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

4. Fibroblast growth factor 21 is a hepatokine involved in MASLD progression;United European Gastroenterology Journal;2024-06-18

5. Oligonucleotide therapies for nonalcoholic steatohepatitis;Molecular Therapy - Nucleic Acids;2024-06